26 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
” and is incorporated herein by reference.
Item 13. Certain Relationships, Related Transactions and Director Independence
Information required by this item … will be contained in our Definitive Proxy Statement under the headings “Certain Relationships and Related Party Transactions” and “Independence
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
Analyst Independence. The Company acknowledges that each Underwriter’s research analysts and research departments are required to be independent from its
PRE 14A
4prl4
12 Mar 21
Preliminary proxy
8:30am